Evaluating Alteplase Use in Minor Ischemic Stroke: Insights from a Nationwide Chinese Registry
A nationwide Chinese registry analysis reveals no overall benefit of intravenous alteplase in minor ischemic stroke but suggests select subgroups, especially those with disabling symptoms or higher NIHSS scores, may experience improved functional outcomes.










